← Leaderboards
Tzu-Yin Lin
Theranostec, Inc.
$4,324,750
Attributed
$4,749,644
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2019–24$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,749,644 · 4
By mechanism
R44$4,049,645 · 2
R43$699,999 · 2
Top collaborators
- Tzu-Yin Lin1 shared
Others in their field
Other Emerging Leaders on “Tissues”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$61,115,130
- Leonard Freedman · Leidos Biomedical Research, Inc.$54,559,980
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Evan Z Macosko · Broad Institute, Inc.$33,867,067
Research focus
TissuesNanoformulationSmall Business Innovation Research GrantDrug Delivery SystemsNanoparticleTumorSiteChemotherapyAnimal ModelMalignant NeoplasmsOperative Surgical ProceduresMortalitySurvival RateDoseDoxorubicinQuality Of LifeFirst-In-HumanFda ApprovedGenerationsDesignInnovationStructureAntineoplastic AgentsClinical Translation
Grant awards (7)
Transformable Theranostics for imaging-guided interventions in head and neck squamous cell carcinoma$719,958
R44 · FY2024 · CA · contact PI
Transformable Theranostics for imaging-guided interventions in head and neck squamous cell carcinoma$849,788
R44 · FY2023 · CA · contact PI
Sub-100 nm and scalable self-therapeutic nanoparticles to target autophagy in pancreatic cancer$399,999
R43 · FY2022 · CA · contact PI
Transformable Theranostics for imaging-guided interventions in head and neck squamous cell carcinoma$480,254
R44 · FY2021 · CA · contact PI
Extremely long tumor retention, on-demand releasing Nano-Taxel for eradicating ovarian cancers$1,496,599
R44 · FY2020 · CA · contact PI
Extremely long tumor retention, on-demand releasing Nano-Taxel for eradicating ovarian cancers$503,046
R44 · FY2019 · CA · contact PI
Transformable nano-theranostics for image-guided interventions in head and neck squamous cell carcinoma$300,000
R43 · FY2019 · CA · contact PI